|
End-of-day quote
Shenzhen S.E.
2026-09-10
|
5-day change | 1st Jan Change | ||
| 58.39 CNY | -1.43% |
|
-3.30% | -2.15% |
| Market Cap | 4.61B 687M 591M 557M 508M 949M 65.68B 958M 6.64B 2.55B 33.31B 2.58B 2.52B 106B | P/E 2024 |
-22.7x | P/E 2025 | -46.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4.94B 736M 633M 597M 544M 1.02B 70.33B 1.03B 7.11B 2.74B 35.67B 2.76B 2.7B 113B | EV / Sales 2024 |
6.46x | EV / Sales 2025 | 32.7x |
| Free-Float |
30.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.43% | ||
| 1 week | -3.30% | ||
| Current month | +1.02% | ||
| 1 month | +5.26% | ||
| 3 months | -17.83% | ||
| 6 months | -35.49% | ||
| Current year | -2.15% |
| 1 week | 57.3 |  | 63.66 |
| 1 month | 51.5 | | 63.66 |
| Current year | 44.55 | | 98.29 |
| 1 year | 39.1 | | 98.29 |
| 3 years | 12.6 | | 98.29 |
| 5 years | 12.6 | | 98.29 |
| 10 years | 12.6 | | 98.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Deng
CEO | Chief Executive Officer | 60 | 2018-11-30 |
Chao Li
DFI | Director of Finance/CFO | 47 | 2017-04-30 |
Fen Jin
DFI | Director of Finance/CFO | 46 | 2017-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Fei Liu
BRD | Director/Board Member | 48 | 2020-02-20 |
Yong Deng
CHM | Chairman | 60 | 2017-11-30 |
Shao Zhong Zhang
BRD | Director/Board Member | 70 | 2020-02-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.43% | -3.30% | +33.40% | +115.22% | 697M | |
| -0.11% | -3.16% | +48.82% | +88.56% | 1,002B | |
| -0.27% | -4.34% | +51.52% | +63.75% | 644B | |
| +1.63% | -2.00% | +20.49% | +71.10% | 443B | |
| -0.63% | -1.06% | +28.11% | +34.59% | 343B | |
| +0.43% | -14.61% | +9.88% | +27.26% | 262B | |
| +0.93% | -1.82% | -1.82% | +8.41% | 245B | |
| -2.25% | -13.88% | +37.33% | +46.14% | 212B | |
| -0.90% | -5.09% | -15.47% | -57.75% | 199B | |
| -0.58% | -4.24% | +25.65% | +87.97% | 181B | |
| Average | -0.11% | -4.95% | +23.79% | +48.52% | 353.04B | |
| Weighted average by Cap. | +0.33% | -4.24% | +31.84% | +55.69% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 241M 35.85M 30.83M 29.09M 26.5M 49.54M 3.43B 49.99M 346M 133M 1.74B 135M 132M 5.52B | 154M 22.97M 19.76M 18.64M 16.98M 31.74M 2.2B 32.03M 222M 85.44M 1.11B 86.27M 84.38M 3.54B |
| Net income | -62.67M -9.34M -8.03M -7.58M -6.9M -12.9M -893M -13.02M -90.23M -34.73M -453M -35.06M -34.3M -1.44B | -102M -15.22M -13.09M -12.35M -11.25M -21.04M -1.46B -21.23M -147M -56.62M -738M -57.17M -55.92M -2.34B |
| Net Debt | 135M 20.07M 17.26M 16.28M 14.83M 27.73M 1.92B 27.98M 194M 74.64M 973M 75.36M 73.71M 3.09B | 327M 48.68M 41.87M 39.5M 35.99M 67.27M 4.65B 67.89M 470M 181M 2.36B 183M 179M 7.5B |
Employees
461
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | CN¥58.39 | -1.43% | 587,000 |
| 26-09-09 | CN¥59.24 | -1.48% | 712,300 |
| 26-09-08 | CN¥60.13 | -1.51% | 890,200 |
| 26-09-07 | CN¥61.05 | -0.15% | 891,602 |
| 26-09-04 | CN¥61.14 | -1.02% | 1,070,800 |
- Stock Market
- Stocks
- 301075 Stock
Select your edition
All financial news and data tailored to specific country editions
